Company Profiles

driven by the PitchBook Platform

Collaborative Drug Discovery

Collaborative Drug Discovery
2004 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Grant LATEST DEAL TYPE
$1.5M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a Web based software platform designed to organize preclinical research data for scientists. The company's Web based software platform offers a database to organize chemical structures and biological study data and collaborate with internal or external partners through the use of Internet, enabling scientists to make progress in their researches with authentic data and get efficient results.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Database Software
Primary Office
1633 Bayshore Highway
Suite 342
Burlingame, CA 94010
United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Collaborative Drug Discovery’s full profile, request a free trial.

Collaborative Drug Discovery Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 27-Mar-2017 $1.5M 00.000 Completed Generating Revenue
5. Grant 17-Jun-2015 00.00 00.000 Completed Generating Revenue
4. Grant 13-Jan-2011 00.00 00.000 Completed Generating Revenue
3. Early Stage VC (Series B) 04-Jan-2006 00000 00.000 00.00 Completed Startup
2. Early Stage VC (Series A2) 20-Dec-2005 $774K $1.02M 00.000 Completed Startup
1. Angel (individual) $250K $250K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Collaborative Drug Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.00 00.0 00.0 00 00.0 00
Series A2 0,000,000 00.00 00.0 00.0 00 00.0 00.000
Series A1 250,000 $0.05 $1 $1 1x $1 8%
To view this company’s complete Cap Table, request access »

Collaborative Drug Discovery Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
SRI International Venture Capital Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Founders Fund Venture Capital Minority 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Collaborative Drug Discovery Executive Team (6)

Name Title Board
Seat
Contact
Info
Barry Bunin Ph.D Founder, Chief Executive Officer, Board Member & President
Krishna Dole Chief Technology and Security Officer
Kellan Gregory Director of Product Excellence
Sylvia Ernst Head, Sales and Sales Operations

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Collaborative Drug Discovery Board Members (3)

Name Representing Role Since Contact
Info
Alpheus Bingham Ph.D Self Board Member 000 0000
Ed Niehaus Self Chairman 000 0000
Peter Cohan Self Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com